Active Ingredient: LAMIVUDINE; TENOFOVIR DISOPROXIL FUMARATE
Proprietary Name: CIMDUO
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 300MG;300MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code:
Application Number: N022141
Product Number: 001
Approval Date: Feb 28, 2018
Applicant Holder Full Name: MYLAN LABORATORIES LTD
Marketing Status:
Prescription
Patent and Exclusivity Information